I don't know that would be exciting but listening to the CEO in the last conference he had a whole entire plan in place already for marketing the drug upon approval knew the exact amount of reps to use and everything.. But Money Always Talks and a Buyout is always out there... especially when there hasn't been an improved drug in over 20 years by FDA for this.
Feel like getting real close to something special here......
News 
Market Data 
Discover 
